Role of C-reactive protein in renal transplantation

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

There has been growing interest in the potential value of pre-transplant inflammatory markers as predictors of outcomes in transplant patients. The most widely studied marker of inflammation is C-Reactive Protein (CRP), an acute phase reactant protein synthesized by the liver in response to interleukin 6, tumor necrosis factor- α and interleukin 1β. High levels of CRP, therefore, are reflective of a pro-inflammatory state. Moreover, CRP also has pro-inflammatory effects of its own such as complement activation and stimulation of natural killer cell activity. There is a substantial existing body of literature on the predictive value of serum CRP measurements, even at a single point in time, in adults with chronic kidney disease. CRP levels are elevated in adults with chronic kidney disease, even in the early stages, with levels being even higher in dialysis patients. High serum levels of CRP are predictive of future cardiac disease and mortality in dialysis patients, patients with coronary artery disease and even in healthy individuals. There are much less data on the predictive value and role of CRP in the post-transplant population, which potentially has more to gain from the identification of a non-invasive biomarker that could predict adverse events. The purpose of this review is to discuss the data pertaining to the utility of CRP measurements in adults and children after transplantation.

Original languageEnglish (US)
Title of host publicationC-Reactive Protein: New Research
PublisherNova Science Publishers, Inc.
Pages27-34
Number of pages8
ISBN (Print)9781606922378
StatePublished - 2009

Fingerprint

C-Reactive Protein
Kidney Transplantation
Transplants
Dialysis
Acute-Phase Proteins
Chronic Renal Insufficiency
Complement Activation
Biomarkers
Interleukin-1
Natural Killer Cells
Liver
Blood Proteins
Coronary Artery Disease
Heart Diseases
Interleukin-6
Tumor Necrosis Factor-alpha
Transplantation
Chemical activation
Inflammation
Mortality

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Butani, L. (2009). Role of C-reactive protein in renal transplantation. In C-Reactive Protein: New Research (pp. 27-34). Nova Science Publishers, Inc..

Role of C-reactive protein in renal transplantation. / Butani, Lavjay.

C-Reactive Protein: New Research. Nova Science Publishers, Inc., 2009. p. 27-34.

Research output: Chapter in Book/Report/Conference proceedingChapter

Butani, L 2009, Role of C-reactive protein in renal transplantation. in C-Reactive Protein: New Research. Nova Science Publishers, Inc., pp. 27-34.
Butani L. Role of C-reactive protein in renal transplantation. In C-Reactive Protein: New Research. Nova Science Publishers, Inc. 2009. p. 27-34
Butani, Lavjay. / Role of C-reactive protein in renal transplantation. C-Reactive Protein: New Research. Nova Science Publishers, Inc., 2009. pp. 27-34
@inbook{ec68ed042b024026b53d88209fbf4bf5,
title = "Role of C-reactive protein in renal transplantation",
abstract = "There has been growing interest in the potential value of pre-transplant inflammatory markers as predictors of outcomes in transplant patients. The most widely studied marker of inflammation is C-Reactive Protein (CRP), an acute phase reactant protein synthesized by the liver in response to interleukin 6, tumor necrosis factor- α and interleukin 1β. High levels of CRP, therefore, are reflective of a pro-inflammatory state. Moreover, CRP also has pro-inflammatory effects of its own such as complement activation and stimulation of natural killer cell activity. There is a substantial existing body of literature on the predictive value of serum CRP measurements, even at a single point in time, in adults with chronic kidney disease. CRP levels are elevated in adults with chronic kidney disease, even in the early stages, with levels being even higher in dialysis patients. High serum levels of CRP are predictive of future cardiac disease and mortality in dialysis patients, patients with coronary artery disease and even in healthy individuals. There are much less data on the predictive value and role of CRP in the post-transplant population, which potentially has more to gain from the identification of a non-invasive biomarker that could predict adverse events. The purpose of this review is to discuss the data pertaining to the utility of CRP measurements in adults and children after transplantation.",
author = "Lavjay Butani",
year = "2009",
language = "English (US)",
isbn = "9781606922378",
pages = "27--34",
booktitle = "C-Reactive Protein: New Research",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Role of C-reactive protein in renal transplantation

AU - Butani, Lavjay

PY - 2009

Y1 - 2009

N2 - There has been growing interest in the potential value of pre-transplant inflammatory markers as predictors of outcomes in transplant patients. The most widely studied marker of inflammation is C-Reactive Protein (CRP), an acute phase reactant protein synthesized by the liver in response to interleukin 6, tumor necrosis factor- α and interleukin 1β. High levels of CRP, therefore, are reflective of a pro-inflammatory state. Moreover, CRP also has pro-inflammatory effects of its own such as complement activation and stimulation of natural killer cell activity. There is a substantial existing body of literature on the predictive value of serum CRP measurements, even at a single point in time, in adults with chronic kidney disease. CRP levels are elevated in adults with chronic kidney disease, even in the early stages, with levels being even higher in dialysis patients. High serum levels of CRP are predictive of future cardiac disease and mortality in dialysis patients, patients with coronary artery disease and even in healthy individuals. There are much less data on the predictive value and role of CRP in the post-transplant population, which potentially has more to gain from the identification of a non-invasive biomarker that could predict adverse events. The purpose of this review is to discuss the data pertaining to the utility of CRP measurements in adults and children after transplantation.

AB - There has been growing interest in the potential value of pre-transplant inflammatory markers as predictors of outcomes in transplant patients. The most widely studied marker of inflammation is C-Reactive Protein (CRP), an acute phase reactant protein synthesized by the liver in response to interleukin 6, tumor necrosis factor- α and interleukin 1β. High levels of CRP, therefore, are reflective of a pro-inflammatory state. Moreover, CRP also has pro-inflammatory effects of its own such as complement activation and stimulation of natural killer cell activity. There is a substantial existing body of literature on the predictive value of serum CRP measurements, even at a single point in time, in adults with chronic kidney disease. CRP levels are elevated in adults with chronic kidney disease, even in the early stages, with levels being even higher in dialysis patients. High serum levels of CRP are predictive of future cardiac disease and mortality in dialysis patients, patients with coronary artery disease and even in healthy individuals. There are much less data on the predictive value and role of CRP in the post-transplant population, which potentially has more to gain from the identification of a non-invasive biomarker that could predict adverse events. The purpose of this review is to discuss the data pertaining to the utility of CRP measurements in adults and children after transplantation.

UR - http://www.scopus.com/inward/record.url?scp=84895203495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895203495&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84895203495

SN - 9781606922378

SP - 27

EP - 34

BT - C-Reactive Protein: New Research

PB - Nova Science Publishers, Inc.

ER -